-+ 0.00%
-+ 0.00%
-+ 0.00%

Aldeyra Expects Cash to Fund Operations Into 2029

PUBT·11/05/2026 22:46:23
Listen to the news
Aldeyra Expects Cash to Fund Operations Into 2029
  • Aldeyra Therapeutics expects its cash and cash equivalents to fund operations into 2029.
  • Cash and cash equivalents totaled $41 million as of September 30, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aldeyra Therapeutics Inc. published the original content used to generate this news brief on November 05, 2026, and is solely responsible for the information contained therein.